Correlation Between Homologous Recombination Deficiency and Response to Olaparib in Patients With Recurrent Epithelial Ovarian Cancer (EOC)
Latest Information Update: 28 Jun 2023
At a glance
- Drugs Olaparib (Primary)
- Indications Carcinoma; Endometrial cancer; Ovarian cancer
- Focus Therapeutic Use
- Acronyms FAB
- 09 Mar 2021 New trial record